Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 3693007016 | Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module | 
| 3693008014 | Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module | 
| 3693009018 | Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous solution | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous solution | Has manufactured dose form | Conventional release cutaneous solution | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous solution | Is a | Product containing clindamycin in topical dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous solution | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous solution | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous solution | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous solution | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous solution | Has precise active ingredient | Clindamycin phosphate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous solution | Has basis of strength substance | Clindamycin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous solution | Has concentration strength numerator value | 10 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous solution | Is a | Product containing only clindamycin in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous solution | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
This concept is not in any reference sets